Oncology Testing Services
The completion of the human genome project has ushered in a new era of diagnostics that moves us closer to understanding the molecular causes for complex diseases, particularly cancer. As a result, the landscape of cancer management is undergoing significant change. This presents a major opportunity for advanced oncology testing.
The goal of CTL's testing servives is to empower physicians and cancer patients by providing a means with which to make informed, individualized treatment decisions based on cellular and genetic analyses of tumor tissues matched to their genetic treatment response profiles. The company is following a dual-strategy towards this goal - providing currently existing tests as a clinical laboratory service, and integrating new tests under development by the company into cancer test panels. The company plans to capitalize on the growth that is anticipated over the next five to ten years in the cancer diagnostics market.